As of 2026-04-04, the Relative Valuation of Shanghai RAAS Blood Products Co Ltd (002252.SZ) is 5.94 CNY. This relative valuation is based on P/E multiples. With the latest stock price at 5.77 CNY, the upside of Shanghai RAAS Blood Products Co Ltd based on Relative Valuation is 2.9%.
The range of the Relative Valuation is 5.70 - 6.35 CNY.
| Range | Selected | |
| Trailing P/E multiples | 24.4x - 26.0x | 24.9x |
| Forward P/E multiples | 17.6x - 19.6x | 18.4x |
| Fair Price | 5.70 - 6.35 | 5.94 |
| Upside | -1.2% - 10.0% | 2.9% |
| Date | P/E |
| 2026-04-02 | 24.83 |
| 2026-04-01 | 24.88 |
| 2026-03-31 | 24.50 |
| 2026-03-30 | 24.54 |
| 2026-03-27 | 24.62 |
| 2026-03-26 | 24.54 |
| 2026-03-25 | 24.67 |
| 2026-03-24 | 24.54 |
| 2026-03-23 | 24.20 |
| 2026-03-20 | 25.34 |
| 2026-03-19 | 25.76 |
| 2026-03-18 | 26.05 |
| 2026-03-17 | 26.14 |
| 2026-03-16 | 26.14 |
| 2026-03-13 | 26.22 |
| 2026-03-12 | 26.35 |
| 2026-03-11 | 26.39 |
| 2026-03-10 | 26.27 |
| 2026-03-09 | 26.27 |
| 2026-03-06 | 26.27 |
| 2026-03-05 | 25.97 |
| 2026-03-04 | 25.97 |
| 2026-03-03 | 26.52 |
| 2026-03-02 | 26.73 |
| 2026-02-27 | 26.48 |
| 2026-02-26 | 26.52 |
| 2026-02-25 | 26.52 |
| 2026-02-24 | 26.35 |
| 2026-02-13 | 26.27 |
| 2026-02-12 | 26.43 |
| 2026-02-11 | 26.60 |
| 2026-02-10 | 26.69 |
| 2026-02-09 | 26.64 |
| 2026-02-06 | 26.56 |
| 2026-02-05 | 26.60 |
| 2026-02-04 | 26.64 |
| 2026-02-03 | 26.39 |
| 2026-02-02 | 26.35 |
| 2026-01-30 | 26.52 |
| 2026-01-29 | 26.77 |
| 2026-01-28 | 26.73 |
| 2026-01-27 | 26.90 |
| 2026-01-26 | 27.49 |
| 2026-01-23 | 26.69 |
| 2026-01-22 | 26.56 |
| 2026-01-21 | 26.52 |
| 2026-01-20 | 26.73 |
| 2026-01-19 | 26.60 |
| 2026-01-16 | 26.52 |
| 2026-01-15 | 26.90 |